Skip to content
ClinCalc Pro
Menu
Antiprotozoal / Antipneumocystis

Atovaquone

Brand names: Wellvone

Atovaquone is an antiprotozoal agent used for the treatment and prevention of Pneumocystis jirovecii pneumonia and, combined with proguanil, for malaria.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It inhibits the parasite cytochrome bc1 complex, disrupting mitochondrial electron transport and pyrimidine synthesis.

Prescribing in practice

  • Absorption is poor and significantly increased by fatty food, so it should be taken with food to ensure efficacy.
  • It is an alternative in patients intolerant of co-trimoxazole for Pneumocystis pneumonia, generally in milder disease.
  • Plasma concentrations may be reduced by interacting drugs such as rifampicin, potentially compromising efficacy.

Monitoring

Monitor clinical response and, where relevant, ensure adequate absorption by confirming it is taken with food.

Counselling the patient

  • Always take with a fatty meal to help your body absorb the medicine.
  • Report worsening breathlessness, fever or cough.
  • Do not stop preventive treatment without advice.

Evidence & guidelines

Atovaquone is recommended as an alternative agent for Pneumocystis jirovecii pneumonia and, with proguanil, for malaria in current guidance.

Reference: BHIVA Guidelines on the management of opportunistic infection (2019); NICE HIV management guidelines; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.